CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2008 Piper Jaffray Europe Conference on Wednesday, June 25, 2008, at 10:20 a.m. BST (5:20 a.m. ET) at the AndAZ London (formerly the Great Eastern Hotel) in London, UK.
